Tag Archives: PMPRB
Independence, Influence & Power: Canada’s Failed Medicine Pricing Reforms
Matthew Herder presents his opening statement to the House of Commons’ Standing Committee on Health on May 2, 2023. In February, Herder resigned from the Patented Medicine Prices Review Board (PMPRB).
Just Price for Drugs: The eleventh hour
Marc-André Gagnon urges modernization and fairness in the pricing of patented drugs in Canada
Impact Ethics 